Our major aim in this joint project between the University of Pécs, Department of Immunology and Biotechnology, and the Department of Public Health Service Baranja County, Osijek – is to earn a clear and evidence based status report of immunity protection of cross-borde

Many business intelligence surveys demonstrate that Digital Realities (Virtual reality and Augmented reality) are becoming a huge market trend in many sectors, and North America is taking the lead in this emerging domain.

The overall aim of the SPRING project is to present an integrated water resource management for reliable water supply for all needs that involve; developing innovative simple to operate bio oxidation systems for treatment of polluted water bodies (stagnant and flowing),

Smart specialisation is an essential principle of European regional policies, aimed at increasing efficiency in research and innovation investments.

The Joint Action on Rare Cancers (JARC) is aimed to integrate and maximize efforts of the European Union (EU) Commission, EU Member States and all stakeholders to advance quality of care and research on rare cancers.

ODYSSEUS aims at Coal-to-Liquids Supply Chain (CLSC) integration and enhanced assessment of operational, economic and environmental risks during or after mine operation in unfavourable geological settings for potential high coal production areas in European medium- to l

This EU-Horizon2020 project aims to develop Financial and Institutional Reforms to build an Entrepreneurial Society (FIRES) in Europe.

SMART GROUND aims at improving the availability and accessibility of data and information on SRM (Secondary Raw Materials) in the EU territory, while creating collaborations and synergies among the different stakeholders involved in the SRM value chain.

There are many efforts at European level to improve our ability to monitor health and to prevent, detect, treat and manage disease so that active and healthy ageing can be promoted.

Due to the rise in cancer and multiple chronic disease, the number of patients with refractory symptoms, ie severe symptoms where conventional treatment options fail, is likely to increase.